Stock Analysis on Net

Intuitive Surgical Inc. (NASDAQ:ISRG)

$24.99

Economic Value Added (EVA)

Microsoft Excel

EVA is registered trademark of Stern Stewart.

Economic value added or economic profit is the difference between revenues and costs,where costs include not only expenses, but also cost of capital.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Economic Profit

Intuitive Surgical Inc., economic profit calculation

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net operating profit after taxes (NOPAT)1
Cost of capital2
Invested capital3
 
Economic profit4

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 NOPAT. See details »

2 Cost of capital. See details »

3 Invested capital. See details »

4 2025 Calculation
Economic profit = NOPAT – Cost of capital × Invested capital
= × =


The financial trajectory between 2021 and 2025 demonstrates a period of aggressive capital expansion paired with fluctuating operational efficiency relative to the cost of capital. While operational profits showed strong growth in the later years, the rapid increase in the capital base created significant pressure on the generation of economic value.

Net Operating Profit After Taxes (NOPAT)
A contraction in NOPAT occurred in 2022, falling to 1,187,823 thousand US$ from 1,700,018 thousand US$ in 2021. Subsequently, a strong recovery trend was established, with profits increasing annually to reach 2,976,548 thousand US$ by 2025, representing a significant expansion in operational earnings.
Invested Capital and Cost of Capital
Invested capital experienced a sustained and substantial increase, growing from 4,517,800 thousand US$ in 2021 to 11,374,500 thousand US$ in 2025. This expansion occurred while the cost of capital remained remarkably stable, maintaining a consistent level of approximately 25.3% throughout the entire period.
Economic Profit Trends
Economic profit exhibited high volatility, transitioning from a positive 557,207 thousand US$ in 2021 to negative values in 2022 and 2023, with the deficit peaking at -214,523 thousand US$. This suggests that during the mid-period, the growth in invested capital outpaced the generation of NOPAT relative to the cost of capital. Although economic profit returned to positive territory in 2024 at 269,059 thousand US$, it declined to 99,500 thousand US$ in 2025. This decline in 2025, despite the highest recorded NOPAT, is attributable to the sharp increase in invested capital, which raised the capital charge and eroded the net economic gain.

Net Operating Profit after Taxes (NOPAT)

Intuitive Surgical Inc., NOPAT calculation

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net income attributable to Intuitive Surgical, Inc.
Deferred income tax expense (benefit)1
Increase (decrease) in allowances2
Increase (decrease) in deferred revenue3
Increase (decrease) in equity equivalents4
Interest expense
Interest expense, operating lease liability5
Adjusted interest expense
Tax benefit of interest expense6
Adjusted interest expense, after taxes7
(Gain) loss on marketable securities
Investment income, before taxes
Tax expense (benefit) of investment income8
Investment income, after taxes9
Net income (loss) attributable to noncontrolling interest
Net operating profit after taxes (NOPAT)

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 Elimination of deferred tax expense. See details »

2 Addition of increase (decrease) in allowances.

3 Addition of increase (decrease) in deferred revenue.

4 Addition of increase (decrease) in equity equivalents to net income attributable to Intuitive Surgical, Inc..

5 2025 Calculation
Interest expense on capitalized operating leases = Operating lease liability × Discount rate
= × =

6 2025 Calculation
Tax benefit of interest expense = Adjusted interest expense × Statutory income tax rate
= × 21.00% =

7 Addition of after taxes interest expense to net income attributable to Intuitive Surgical, Inc..

8 2025 Calculation
Tax expense (benefit) of investment income = Investment income, before tax × Statutory income tax rate
= × 21.00% =

9 Elimination of after taxes investment income.


Net income attributable to Intuitive Surgical, Inc. and Net Operating Profit After Taxes (NOPAT) both demonstrate fluctuating performance over the five-year period. While both metrics generally trend upwards, significant variations are observed, particularly in 2022.

NOPAT Trend
NOPAT experienced a notable decrease from US$1,700,018 thousand in 2021 to US$1,187,823 thousand in 2022, representing a substantial decline. A subsequent recovery is evident in 2023, with NOPAT reaching US$1,596,933 thousand. Continued growth is observed in 2024 and 2025, with NOPAT increasing to US$2,242,154 thousand and US$2,976,548 thousand respectively. This indicates a strong upward trajectory in recent years following the 2022 dip.
Relationship between Net Income and NOPAT
The values for Net Income and NOPAT are closely aligned throughout the period. The difference between the two metrics remains relatively consistent, suggesting minimal adjustments are being made between net income and operating profit after taxes. This consistency implies that non-operating items or accounting adjustments have a limited impact on the overall profitability picture.
Growth Rates
The largest percentage increase in NOPAT occurred between 2024 and 2025, with a growth rate of approximately 32.7%. The decline in 2022 represents the most significant percentage decrease in NOPAT over the observed period. The recovery from 2022 to 2023 shows a growth rate of approximately 34.4%.

Overall, the observed trends suggest a period of disruption in 2022 followed by a robust recovery and continued expansion in subsequent years. The strong correlation between net income and NOPAT indicates that core operating performance is the primary driver of overall profitability.


Cash Operating Taxes

Intuitive Surgical Inc., cash operating taxes calculation

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Income tax expense
Less: Deferred income tax expense (benefit)
Add: Tax savings from interest expense
Less: Tax imposed on investment income
Cash operating taxes

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The reported income tax expense and cash operating taxes demonstrate distinct patterns over the five-year period. Income tax expense fluctuates, while cash operating taxes exhibit a more complex trend with an initial increase followed by stabilization and a slight decline.

Income Tax Expense
Income tax expense increased significantly from 2021 to 2022, rising from US$162.2 million to US$262.4 million. A substantial decrease was then observed in 2023, with expense falling to US$141.6 million. This was followed by increases in both 2024 and 2025, reaching US$336.3 million and US$434.8 million respectively. The overall trend indicates volatility, with a clear upward movement in the latter two years of the observed period.
Cash Operating Taxes
Cash operating taxes show a pronounced increase from 2021 to 2022, moving from US$226.7 million to US$448.3 million. The rate of increase slowed in 2023, with taxes reported at US$423.0 million. Values for 2024 and 2025 are US$472.97 million and US$417.4 million, respectively. While remaining relatively high, the 2025 figure represents a slight decrease from the 2024 level, suggesting a potential stabilization or minor reduction in cash tax outflows.

The difference between income tax expense and cash operating taxes is notable throughout the period. Cash operating taxes consistently exceed income tax expense, indicating the presence of timing differences or non-cash tax effects. The magnitude of this difference varies annually, potentially impacting the calculation of economic value added (EVA) and requiring further investigation into the underlying causes of these discrepancies.

Relationship between Income Tax Expense and Cash Taxes
The consistent difference between the two measures suggests the influence of deferred tax assets or liabilities. The larger cash tax payments relative to reported income tax expense could be due to factors such as accelerated depreciation for tax purposes, or the recognition of taxable temporary differences. Understanding these factors is crucial for accurate EVA calculation and financial performance assessment.

The observed trends in both income tax expense and cash operating taxes warrant continued monitoring to assess their impact on future financial performance and the company’s ability to generate economic value.


Invested Capital

Intuitive Surgical Inc., invested capital calculation (financing approach)

US$ in thousands

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Operating lease liability1
Total reported debt & leases
Total Intuitive Surgical, Inc. stockholders’ equity
Net deferred tax (assets) liabilities2
Allowances3
Deferred revenue4
Equity equivalents5
Accumulated other comprehensive (income) loss, net of tax6
Noncontrolling interest in joint venture
Adjusted total Intuitive Surgical, Inc. stockholders’ equity
Construction-in-process7
Available-for-sale marketable securities8
Invested capital

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 Addition of capitalized operating leases.

2 Elimination of deferred taxes from assets and liabilities. See details »

3 Addition of allowance for doubtful accounts receivable.

4 Addition of deferred revenue.

5 Addition of equity equivalents to total Intuitive Surgical, Inc. stockholders’ equity.

6 Removal of accumulated other comprehensive income.

7 Subtraction of construction-in-process.

8 Subtraction of available-for-sale marketable securities.


The invested capital of the company demonstrates a consistent upward trend over the five-year period. Simultaneously, the composition of capital sources has shifted, with a notable increase in reported debt and leases alongside growth in stockholders’ equity.

Invested Capital Trend
Invested capital increased from US$4,517.8 million in 2021 to US$11,374.5 million in 2025. This represents a cumulative increase of 151.8% over the period. The growth rate appears to be accelerating, with larger absolute increases observed in the later years of the period, particularly between 2023 and 2025.
Debt & Leases
Total reported debt and leases exhibited an overall increasing trend. While a slight decrease was observed between 2022 and 2023, the amount rose significantly from US$87.0 million in 2021 to US$170.9 million in 2025, representing a 96.4% increase. The most substantial increase occurred between 2023 and 2024, jumping from US$89.8 million to US$146.0 million.
Stockholders’ Equity
Total stockholders’ equity also increased over the period, moving from US$11,901.1 million in 2021 to US$17,824.0 million in 2025, a 49.8% increase. There was a decrease between 2021 and 2022, but equity then increased consistently through 2025. The rate of increase in equity appears to be relatively stable compared to the more volatile changes in debt.
Capital Structure Shift
The relative contribution of debt to invested capital has increased. In 2021, debt and leases represented approximately 2.0% of invested capital. By 2025, this proportion had risen to approximately 1.5%. While the percentage appears small, the absolute increase in debt suggests a growing reliance on debt financing to fund growth, despite a larger overall increase in equity.

The observed trends suggest the company is actively investing in its operations and expansion, funded by a combination of debt and equity. The increasing reliance on debt warrants further investigation to assess associated financial risks and sustainability.


Cost of Capital

Intuitive Surgical Inc., cost of capital calculations

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Operating lease liability3 ÷ = × × (1 – 21.00%) =
Total:

Based on: 10-K (reporting date: 2025-12-31).

1 US$ in thousands

2 Equity. See details »

3 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Operating lease liability3 ÷ = × × (1 – 21.00%) =
Total:

Based on: 10-K (reporting date: 2024-12-31).

1 US$ in thousands

2 Equity. See details »

3 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Operating lease liability3 ÷ = × × (1 – 21.00%) =
Total:

Based on: 10-K (reporting date: 2023-12-31).

1 US$ in thousands

2 Equity. See details »

3 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Operating lease liability3 ÷ = × × (1 – 21.00%) =
Total:

Based on: 10-K (reporting date: 2022-12-31).

1 US$ in thousands

2 Equity. See details »

3 Operating lease liability. See details »

Capital (fair value)1 Weights Cost of capital
Equity2 ÷ = × =
Operating lease liability3 ÷ = × × (1 – 21.00%) =
Total:

Based on: 10-K (reporting date: 2021-12-31).

1 US$ in thousands

2 Equity. See details »

3 Operating lease liability. See details »


Economic Spread Ratio

Intuitive Surgical Inc., economic spread ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in thousands)
Economic profit1
Invested capital2
Performance Ratio
Economic spread ratio3
Benchmarks
Economic Spread Ratio, Competitors4
Abbott Laboratories
Elevance Health Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 Economic profit. See details »

2 Invested capital. See details »

3 2025 Calculation
Economic spread ratio = 100 × Economic profit ÷ Invested capital
= 100 × ÷ =

4 Click competitor name to see calculations.


The financial performance from 2021 to 2025 is characterized by a consistent expansion of the capital base contrasted with significant volatility in the ability to generate returns exceeding the cost of capital. While invested capital grew steadily throughout the period, economic profit and the associated spread ratio experienced a period of contraction and value destruction before returning to positive territory.

Invested Capital Trends
A sustained upward trajectory in invested capital is observed, increasing from 4,517,800 thousand US dollars in 2021 to 11,374,500 thousand US dollars by 2025. This represents a substantial growth in the resource base, with the most significant acceleration occurring between 2023 and 2025, indicating aggressive capital deployment or asset accumulation.
Economic Profit Analysis
Economic profit exhibited high volatility, beginning with a peak of 557,207 thousand US dollars in 2021. This was followed by two consecutive years of negative economic profit, reaching a low of -214,523 thousand US dollars in 2023, which signifies a period where the return on invested capital did not cover the cost of that capital. A recovery occurred in 2024 with a return to positive profit of 269,059 thousand US dollars, although this figure declined to 99,500 thousand US dollars in 2025.
Economic Spread Ratio Interpretation
The economic spread ratio mirrors the fluctuations seen in economic profit. A strong positive spread of 12.33% in 2021 transitioned into negative spreads of -3.28% in 2022 and -3.00% in 2023, confirming the destruction of economic value during those years. Although the ratio recovered to 3.45% in 2024, it narrowed significantly to 0.87% in 2025. This downward trend in the spread ratio, despite positive economic profit in the final two years, suggests that the returns are barely exceeding the cost of capital as the invested capital base continues to expand.

Overall, the data indicates a disconnect between capital growth and value creation efficiency. The steady increase in invested capital has not consistently translated into proportional growth in economic profit, resulting in a compressed economic spread by the end of the observed period.


Economic Profit Margin

Intuitive Surgical Inc., economic profit margin calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Selected Financial Data (US$ in thousands)
Economic profit1
 
Revenue
Add: Increase (decrease) in deferred revenue
Adjusted revenue
Performance Ratio
Economic profit margin2
Benchmarks
Economic Profit Margin, Competitors3
Abbott Laboratories
Elevance Health Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 Economic profit. See details »

2 2025 Calculation
Economic profit margin = 100 × Economic profit ÷ Adjusted revenue
= 100 × ÷ =

3 Click competitor name to see calculations.


The financial performance between 2021 and 2025 is characterized by a divergence between consistent revenue expansion and volatile economic profit. While adjusted revenue grew steadily each year, the ability to generate economic profit—returns exceeding the cost of capital—fluctuated significantly, moving from a strong positive position to a deficit before returning to positive territory.

Adjusted Revenue Growth
A consistent upward trajectory is observed in adjusted revenue, which increased from 5,741,800 thousand US$ in 2021 to 10,139,900 thousand US$ by 2025. This represents a sustained growth trend, indicating a widening market presence or increased sales volume over the five-year period.
Economic Profit Volatility
Economic profit exhibited substantial instability. After a peak of 557,207 thousand US$ in 2021, the figure turned negative in 2022 (-176,908 thousand US$) and reached its lowest point in 2023 (-214,523 thousand US$). A recovery occurred in 2024 with a return to positive value creation of 269,059 thousand US$, although this figure declined to 99,500 thousand US$ in 2025.
Economic Profit Margin Analysis
The economic profit margin mirrors the volatility of the absolute economic profit. A high margin of 9.70% in 2021 plummeted to -2.83% in 2022 and -2.99% in 2023, indicating that during these years, the company failed to cover its cost of capital. Although the margin recovered to 3.21% in 2024, it contracted sharply to 0.98% in 2025, suggesting that revenue growth did not translate proportionally into economic value added during the final year of the period.

The data indicates a period of value destruction between 2022 and 2023, followed by a partial recovery. The decline in the economic profit margin in 2025, despite record-high adjusted revenue, suggests an increase in the capital charge or a compression in operating margins that offset the gains from top-line growth.